Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Cardiology ; (12): 282-288, 2022.
Artículo en Chino | WPRIM | ID: wpr-935141

RESUMEN

Objective: To explore the impact of composite clinical worsening (cCW) events and its components on the prognosis of patients with pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH). Methods: This is a retrospective study. Patients who were diagnosed with CHD-PAH in Beijing Anzhen Hospital between January 2007 and July 2018, were included, and their baseline clinical data including demographic, clinical manifestations and New York Heart Association (NYHA) classification were collected retrospectively. All-cause deaths and clinical worsening events were recorded, which included syncope, PAH related hospitalization, NYHA classification deterioration and ≥ 2 PAH related clinical symptoms (dyspnea, hemoptysis, edema, chest pain, palpitations, cyanosis) appearance/progress. Three kinds of cCW events were defined: cCW1 (included PAH related hospitalization, NYHA classification deterioration), cCW2 (increased syncope on the basis of cCW1) and cCW3 (increased ≥ 2 PAH related clinical symptoms appearance/progress on the basis of cCW2). The Kaplan-Meier survival curve was used to analyze the long-term survival of the included patients. Univariate and multivariate Cox regression models were used to evaluate the impact of cCW events and their components on the risk of all-cause mortality. Results: A total of 525 patients with CHD-PAH were included in this study. The median age at diagnosis was 20.7 (11.2, 30.3) years. There were 43.8% children (<18 years), and 68.8% female patients. There were 431 patients (82.1%) with NYHA classification II. A total of 180 patients had PAH symptoms at diagnosis. The median follow-up time was 4.5 (2.6, 6.7) years. Forty-seven patients (9.0%) died during the follow-up period. Survival rates at 1, 5 and 10 years after diagnosis of PAH were 98.0%, 89.9% and 84.4%, respectively. Cox multivariate analysis showed that NYHA classification deterioration (HR=3.901, 95%CI 1.863-8.169, P<0.001), ≥2 PAH symptoms appearance/progress (HR=4.458, 95%CI 1.870-10.625, P<0.001), PAH-related hospitalization (HR=4.058, 95%CI 1.851-8.896, P<0.001) and syncope (HR=11.313, 95%CI 4.860-26.332, P<0.001) were independent predictors of increased risk of death. All 3 kinds of cCW events were significantly associated with the significantly increased risk of death, and cCW2 was highly predictive to increased risk of death (HR=15.476, 95%CI 4.346-37.576, P<0.001). Conclusions: The overall long-term prognosis of CHD-PAH patients in this study is relatively good. cCW events and its components (NYHA classification deterioration, ≥2 PAH symptoms occurrence/worsening, PAH-related hospitalization and syncope) have adverse influence on all-cause death in this patient cohort.


Asunto(s)
Niño , Femenino , Humanos , Masculino , Hipertensión Pulmonar Primaria Familiar/complicaciones , Cardiopatías Congénitas/complicaciones , Hipertensión Pulmonar/complicaciones , Hipertensión Arterial Pulmonar , Estudios Retrospectivos
2.
Artículo en Inglés | IMSEAR | ID: sea-163476

RESUMEN

Severe pulmonary Arterial Hypertension with Pulmonary Edema with Sepsis in a postnatal mother with Atrial Septal Defect (ASD) followed by LSCS is uncommon. Atrial Septal Defect (ASD) is the commonest adult congenital heart defect (CHD). 15 % of these patients will eventually develop pulmonary hypertension if left untreated. ASD closure is not recommended when pulmonary hypertension is irreversible. Congenital heart disease should be considered in the evaluation of dyspnoea in a young adult. The management of ASD with associated pulmonary hypertension is difficult. It is pertinent that a detailed hemodynamic assessment be undertaken. The present case report focusses on a patient with severe ASD with pulmonary hypertension with pulmonary edema and sepsis who was with 35 weeks of gestation and the control of symptoms during Caesarean section.


Asunto(s)
Adulto , Cesárea/métodos , Hipertensión Pulmonar Primaria Familiar/complicaciones , Hipertensión Pulmonar Primaria Familiar/tratamiento farmacológico , Femenino , Defectos del Tabique Interatrial/complicaciones , Defectos del Tabique Interatrial/tratamiento farmacológico , Humanos , Embarazo , Edema Pulmonar/tratamiento farmacológico , Edema Pulmonar/etiología , Sepsis/etiología , Sepsis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA